Loading...
Successful retreatment with osimertinib after osimertinib-induced acute pulmonary embolism in a patient with lung adenocarcinoma: A case report
Pulmonary embolism (PE) can be life-threatening, and it is challenging to diagnose because of its nonspecific signs and symptoms. PE is also an important potential risk of osimertinib treatment, however, clinical courses regarding retreatment after osimertinib-induced acute pulmonary embolism remain...
Na minha lista:
Udgivet i: | Respir Med Case Rep |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Elsevier
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5121160/ https://ncbi.nlm.nih.gov/pubmed/27896061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2016.11.009 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|